Cayetana Vázquez, Ph.D.
About Cayetana Vázquez, Ph.D.
Cayetana Vázquez, Ph.D., is a Project Manager for the Scientific Portfolio at Exscientia in Oxford, United Kingdom, where she has worked since 2021. She has over seven years of experience in scientific research, specializing in next-generation sequencing and phenotypic screening.
Work at Exscientia
Cayetana Vázquez, Ph.D., has been serving as Project Manager for the Scientific Portfolio at Exscientia since 2021. In this role, she is responsible for overseeing various scientific projects aimed at advancing drug discovery and development. Based in Oxford, England, she has contributed to the company's mission of integrating artificial intelligence with drug design. Her experience in project management and scientific research supports Exscientia's innovative approach to improving healthcare outcomes.
Previous Experience
Prior to her current position, Vázquez worked at Airfinity Ltd as a Senior Analyst for three months in 2021. She also held the role of Principal Scientist (Target Validation) at Ochre Bio from 2020 to 2021, where she focused on target validation processes. Her tenure at Novo Nordisk as a Research Scientist from 2018 to 2020 further solidified her expertise in scientific research. Additionally, she has experience as a Graduate Research Scientist at CRCHUM from 2014 to 2018, contributing to various research initiatives.
Education and Expertise
Cayetana Vázquez earned her Doctor of Philosophy (Ph.D.) from Université de Montréal, completing her studies from 2014 to 2018. She also participated in the Advances in Stem Cell Biology Course at Institut Pasteur in 2014. Vázquez holds a Bachelor of Science (BSc) from UCL, which she completed from 2010 to 2014. Her educational background is complemented by specialized training, including the ASCB-KGI Biotech Mini-Course in 2017. She possesses strong science communication skills and extensive experience in next-generation sequencing and phenotypic screening.
Research and Technical Skills
Vázquez has over seven years of experience in live-cell imaging technologies and project design. Her technical skills are complemented by a robust background in cell and molecular biology research. She is passionate about developing novel approaches and next-generation therapies, focusing on improving healthcare outcomes. Her expertise in scientific research and innovation positions her as a valuable contributor to advancements in the field.